1. Home
  2. MRSN vs SCWO Comparison

MRSN vs SCWO Comparison

Compare MRSN & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • SCWO
  • Stock Information
  • Founded
  • MRSN 2001
  • SCWO 2021
  • Country
  • MRSN United States
  • SCWO United States
  • Employees
  • MRSN N/A
  • SCWO 27
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • MRSN Health Care
  • SCWO Utilities
  • Exchange
  • MRSN Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • MRSN 36.4M
  • SCWO 40.5M
  • IPO Year
  • MRSN 2017
  • SCWO N/A
  • Fundamental
  • Price
  • MRSN $0.35
  • SCWO $0.26
  • Analyst Decision
  • MRSN Buy
  • SCWO
  • Analyst Count
  • MRSN 3
  • SCWO 0
  • Target Price
  • MRSN $4.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • MRSN 3.1M
  • SCWO 290.2K
  • Earning Date
  • MRSN 05-08-2025
  • SCWO 05-14-2025
  • Dividend Yield
  • MRSN N/A
  • SCWO N/A
  • EPS Growth
  • MRSN N/A
  • SCWO N/A
  • EPS
  • MRSN N/A
  • SCWO N/A
  • Revenue
  • MRSN $40,497,000.00
  • SCWO $445,445.00
  • Revenue This Year
  • MRSN N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • MRSN N/A
  • SCWO $106.82
  • P/E Ratio
  • MRSN N/A
  • SCWO N/A
  • Revenue Growth
  • MRSN 9.88
  • SCWO N/A
  • 52 Week Low
  • MRSN $0.26
  • SCWO $0.25
  • 52 Week High
  • MRSN $3.83
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 44.90
  • SCWO 38.13
  • Support Level
  • MRSN $0.31
  • SCWO $0.33
  • Resistance Level
  • MRSN $0.40
  • SCWO $0.30
  • Average True Range (ATR)
  • MRSN 0.05
  • SCWO 0.03
  • MACD
  • MRSN 0.01
  • SCWO -0.00
  • Stochastic Oscillator
  • MRSN 68.09
  • SCWO 8.33

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: